the keynote-407 trial in metastatic squamous nsclc
Published 5 years ago • 307 plays • Length 4:52Download video MP4
Download video MP3
Similar videos
-
0:54
dr. bestvina on the keynote-407 trial in squamous nsclc
-
1:00
dr. raez on the keynote-407 trial in squamous cell carcinoma of the lung
-
3:29
squamous cell frontline therapy: impower 131, keynote-407
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
5:42
role of i/o with chemotherapy in advanced squamous nsclc
-
1:14
dr. halmos on second-line treatment in metastatic squamous nsclc
-
4:18
important data in the squamous nsclc population
-
5:54
pembrolizumab in newly diagnosed squamous nsclc
-
9:33
keynote-407: practice-changing positive trial for advanced squamous nsclc (bmic-039)
-
1:55
dr. kim on the keynote-189 trial in metastatic nsclc
-
3:47
combining chemotherapy & immunotherapy in squamous nsclc
-
5:08
promising immunotherapy trials in squamous nsclc
-
8:19
keynote trial data: pembrolizumab’s role in nsclc
-
2:09
dr. subramanian on the impower131 trial in squamous nsclc
-
5:10
the role of immunotherapy in squamous nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
2:54
advanced squamous nsclc: the impower131 study